Development of an integrated CRISPRi targeting ΔNp63 for treatment of squamous cell carcinoma
M. Yoshida(Kawasaki Medical School), Yoshio Naomoto(Okayama University)
Cited by 36
Related Papers
Inhibition of the Growth Factor MDK/Midkine by a Novel Small Molecule Compound to Treat Non-Small Cell Lung Cancer
|PLoS ONE|2013|74
Inhibition of focal adhesion kinase as a potential therapeutic strategy for imatinib-resistant gastrointestinal stromal tumor
|Molecular Cancer Therapeutics|2009|68
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
|Scientific Reports|2016|56